Selected article for: "animal facility and hematoxylin eosin"

Author: Lien, Gi-Shih; Liu, Jen-Fang; Chien, Ming-Hsien; Hsu, Wei-Tse; Chang, Tzu-Hao; Ku, Chia-Chi; Ji, Andrea Tung-Qian; Tan, Peng; Hsieh, Ting-Lieh; Lee, Liang-Ming; Ho, Jennifer H
Title: The ability to suppress macrophage-mediated inflammation in orbital fat stem cells is controlled by miR-671-5p
  • Document date: 2014_8_13
  • ID: 1i6hni9s_25
    Snippet: Male Balb/c mice were maintained in the animal facility and all experimental protocols were approved by the animal use and care committee of Taipei Medical University-Wan Fang Hospital. The animal model of LPS-induced ALI was established as per our previous report [23] . Briefly, LPS (25 μg in 50 μl sterile saline/mice) was delivered into 8-week-old to 10-week-old mice (BioLASCO Taiwan Co., Ltd, Taipei, Taiwan) via intratracheal injection. Twen.....
    Document: Male Balb/c mice were maintained in the animal facility and all experimental protocols were approved by the animal use and care committee of Taipei Medical University-Wan Fang Hospital. The animal model of LPS-induced ALI was established as per our previous report [23] . Briefly, LPS (25 μg in 50 μl sterile saline/mice) was delivered into 8-week-old to 10-week-old mice (BioLASCO Taiwan Co., Ltd, Taipei, Taiwan) via intratracheal injection. Twenty minutes after LPS injection, 3 × 10 5 OFSCs with or without transfection of miR-671-5p inhibitor in 50 μl phosphate-buffered saline were administrated via the tail vein. Tail vein injection of 50 μl phosphate-buffered saline served as the control. Animals were sacrificed 6 hours after LPS exposure. Lung tissues were removed and stained with hematoxylin and eosin. Each condition was repeated in at least three independent mice.

    Search related documents:
    Co phrase search for related documents
    • animal facility and lung tissue: 1, 2, 3
    • animal model and care committee: 1
    • animal model and independent mouse: 1
    • animal model and intratracheal injection: 1, 2
    • animal model and LPS exposure: 1
    • animal model and LPS induce: 1, 2, 3, 4, 5
    • animal model and LPS injection: 1, 2, 3, 4
    • animal model and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • care committee and experimental protocol: 1, 2, 3, 4, 5, 6, 7
    • care committee and lung tissue: 1, 2
    • eosin hematoxylin stain and lung tissue: 1
    • experimental protocol and LPS induce: 1
    • experimental protocol and LPS injection: 1, 2
    • intratracheal injection and LPS injection: 1, 2, 3, 4, 5, 6
    • intratracheal injection and lung tissue: 1, 2, 3, 4
    • LPS exposure and lung tissue: 1, 2, 3
    • LPS induce and lung tissue: 1, 2, 3